NCT06106113View on ClinicalTrials.gov

Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

February 6, 2023

Study Completion Date

May 30, 2023

Conditions

COVID-19 Pneumonia

Interventions

DRUG

GST-HG171 Tablets

150mg GST-HG171 Tablets

Trial Locations (1)

130021

The first hospital of Jilin University, Changchun

All Listed Sponsors

lead

Fujian Akeylink Biotechnology Co., Ltd.

INDUSTRY